drugset / Trial / NCT00809549

Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery

NCT00809549

Phase 1 Unknown 20 enrolled Ottawa Hospital Research Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

1. Circulating bone marrow and blood vessel precursors home in to sites of ischemia and aid regeneration of injured tissue 2. Increasing the number of circulating precursors will improve in regeneration of damaged brain following ischemic stroke.

Timeline

Start
2006-07
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic 10 ug/kg Subcutaneous

Indications